{
  "id": "977b3216-eeba-431d-b94e-8614eba84235",
  "title": "Zepbound, Mounjaro sales buoy Eli Lilly family endowment",
  "link": "https://seekingalpha.com/news/4449870-zepbound-mounjaro-sales-buoy-eli-lilly-family-endowment?utm_source=feed_news_all\u0026utm_medium=referral\u0026feed_item_type=news",
  "description": "",
  "author": "",
  "published": "Sat, 17 May 2025 15:57:26 -0400",
  "source": "https://seekingalpha.com/market_currents.xml",
  "categories": [
    "lly"
  ],
  "byline": "Jonathan Block",
  "length": 353,
  "excerpt": "Eli Lilly's GLP-1/GIP meds boost Lilly Endowment to $79.9B, surpassing Gates Foundation. Read more here.",
  "siteName": "Seeking Alpha",
  "favicon": "https://seekingalpha.com/samw/static/images/favicon-192x192.png",
  "text": "Healthcarewellesenterprises Sales of Eli Lilly's blockbuster GLP-1/GIP meds Zepbound and Mounjaro, which contain tirzepatide and are approved for, respectively, weight loss and type 2 diabetes, have helped to majorly boost the drugmaker's founders family endowment. The Lilly Endowment's assets have grown Recommended For YouMore Trending NewsSee More »",
  "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w750",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-test-id=\"grid-col-main\"\u003e\u003cdiv data-test-id=\"card-container\"\u003e\u003cheader\u003e\u003cdiv data-test-id=\"quick-links\"\u003e\u003cul\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/healthcare#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Ahealthcare%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eHealthcare\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e\u003c/header\u003e\u003cdiv\u003e\u003cdiv data-test-id=\"content-container\"\u003e\u003cfigure contenteditable=\"false\" data-show-to-all=\"false\" data-type=\"getty-image\"\u003e\u003cpicture\u003e\u003cimg src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w750\" sizes=\"(max-width: 768px) calc(100vw - 36px), (max-width: 1024px) calc(100vw - 132px), (max-width: 1200px) calc(66.6vw - 72px), 600px\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w240 240w\" alt=\"Eli Lilly and Company Headquarters\" width=\"1536px\" height=\"1021px\" data-caption=\"wellesenterprises\" data-id=\"2157849824\" data-image-type=\"Getty\" data-original-src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157849824/image_2157849824.jpg?io=getty-c-w750\" data-source=\"\" data-type=\"getty-image\"/\u003e\u003c/picture\u003e\u003cfigcaption data-type=\"getty-image\"\u003e\u003cp\u003ewellesenterprises\u003c/p\u003e\u003c/figcaption\u003e\u003c/figure\u003e\u003cul\u003e \u003cli\u003eSales of Eli Lilly\u0026#39;s blockbuster GLP-1/GIP meds Zepbound and Mounjaro, which contain tirzepatide and are approved for, respectively, weight loss and type 2 diabetes, have helped to majorly boost the drugmaker\u0026#39;s founders family endowment.\u003c/li\u003e \u003cli\u003eThe Lilly Endowment\u0026#39;s assets have grown\u003c/li\u003e \u003c/ul\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"recommended-section\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"recommended-for-you-card-title\"\u003eRecommended For You\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003csection data-test-id=\"trending-card-container\"\u003e\u003cdiv\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"trending-card-title\"\u003eMore \u003cspan id=\"trending-news\"\u003eTrending News\u003c/span\u003e\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv\u003e\u003cp\u003e\u003ca id=\"cardFooterSeeMore\" data-test-id=\"card-footer-link\" aria-labelledby=\"trending-news cardFooterSeeMore\" href=\"https://seekingalpha.com/market-news#source=first_level_url%3Anews%7Csection%3Amain_content%7Csection_asset%3Amore_trending_news%7Cbutton%3Amore\"\u003e\u003cspan\u003eSee More »\u003c/span\u003e\u003c/a\u003e\u003c/p\u003e\u003c/div\u003e\u003c/section\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "Less than 1 min",
  "publishedTime": "2025-05-17T19:57:26Z",
  "modifiedTime": null
}
